George Kapsalas Patentbüro Paul Rosenich AG

Slides:



Advertisements
Similar presentations
H I R S C H & P A R T N E R S A v o c a t S o l i c i t o r R e c h t s a n w a l t CHEMICAL INVENTIONS IN FRANCE Recent decisions and case law Dr Denis.
Advertisements

Disclaimer: The information provided by the USPTO is meant as an educational resource only and should not be construed as legal advice or written law.
P ROFESSOR R UTH O KEDIJI First to File Patent Systems How the New U.S. System Compares to other Systems Around the World.
Disclaimer: The information provided by the USPTO is meant as an educational resource only and should not be construed as legal advice or written law.
Disclaimer: The information provided by the USPTO is meant as an educational resource only and should not be construed as legal advice or written law.
The International Patent System Amendments to the PCT Regulations as from 1 July 2014.
INTELLECTUAL PROPERTY PROTECTION OFFICE OF PATENT COUNSEL March 16, 2001.
1 1 1 AIPLA American Intellectual Property Law Association USPTO Updates Including Glossary Pilot Program Chris Fildes Fildes & Outland, P.C. IP Practice.
The America Invents Act (AIA) - Rules and Implications of First to File, Prior Art, and Non-obviousness -
September 14, U.S.C. 103(c) as Amended by the Cooperative Research and Technology Enhancement (CREATE) Act (Public Law ) Enacted December.
Disclaimer: The information provided by the USPTO is meant as an educational resource only and should not be construed as legal advice or written law.
Filing Compliant Reexam Requests Andy Kashnikow SPE, Central Reexamination Unit Andy Kashnikow SPE, Central Reexamination Unit June, 2010.
Invention Spotting – Identifying Patentable Inventions Martin Vinsome June 2012.
R.G.C. Jenkins & Co Patents – Designs – Trade Marks.
Determination of Obviousness Practice Under the Genus-Species Guidelines and In re Ochiai; In re Brouwer Sreeni Padmanabhan & James Wilson Supervisory.
Patent Overview by Jeff Woller. Why have Patents? Patents make some people rich – but, does that seem like something the government should protect? Do.
Patents 101 April 1, 2002 And now, for something new, useful and not obvious.
A comparative analysis with a harmonizing perspective A RT. 123(2) EPC AND US W RITTEN D ESCRIPTION 1 © AIPLA 2015 Enrica Bruno - Steinfl & Bruno LLP.
By Paul J. Lee. Disclaimer The opinions and views expressed in these materials are not necessarily those of DexCom and reflect only the personal views.
1 1 AIPLA Firm Logo American Intellectual Property Law Association Hamilton Beach Brands v. Sunbeam Products: Lessons Learned Naomi Abe Voegtli IP Practice.
1 35 U.S.C. § 102(e): The Legislative Fix (S.320) and Serial Abandonment of Provisional Applications Stephen G. Kunin Deputy Commissioner for Patent Examination.
February 19, Recent Changes and Developments in USPTO Practice Prepared by: Office of Patent Legal Administration (OPLA) Robert J. Spar, DirectorJoni.
Patents- Practical Aspects of International Patent Procurement/Prosecution June 2015 Patent Cooperation Treaty (PCT) Practice Overview.
Biotechnology/Chemical/Pharmaceutical Customer Partnership Topic: Biotechnology/Chemical/Pharmaceutical Customer Partnership Topic: Biological Deposits.
Notice of Proposed Rule Making Affecting Claims That Recite Alternatives 1 Robert Clarke, Director Office of Patent Legal Administration (571)
Restriction & Double Patenting Mojdeh Bahar, J.D., M.A., CLP Chief, Cancer Branch Office of Technology Transfer National Institutes of Health U.S. Department.
Christopher J. Fildes Fildes & Outland, P.C. Derivation Proceedings and Prior User Rights.
Patent Application Procedures in Europe by Dr. Ulla Allgayer Patent Attorney in Munich Germany.
Seminar Industrial Property Protection Prague, 4 June 2003 Patent Protection in Europe Heidrun Krestel Liaison Officer Member States Co-operation Programmes.
July 18, U.S.C. 103(c) as Amended by the Cooperative Research and Technology Enhancement (CREATE) Act (Public Law ) Enacted December 10,
1 When is it NOT Appropriate to Restrict? Julie Burke TC1600 QAS
© 2004 VOSSIUS & PARTNER Opposition in the Procedural System by Dr. Johann Pitz AIPPI Hungary, June 2 – 4, 2004 Kecskemét.
Grace Period System under AIA vs. Exception to Loss of Novelty in Japan JPAA International Activities Center Kazuhiro Yamaguchi January 29, 2013 AIPLA.
New Sections 102 & 103 (b) Conditions for Patentability- (1) IN GENERAL- Section 102 of title 35, United States Code, is amended to read as follows: -`Sec.
1 1 1 AIPLA Firm Logo American Intellectual Property Law Association U.S. Implementation of the Hague Agreement For Designs John (Jack) J. Penny, V Event.
INTELLECTUAL PROPERTY LAW FOR NON-IP PRACTITIONERS: ETHICS AND ISSUE SPOTTING FOR EFFECTIVE REPRESENTATION Philip Furgang Furgang & Adwar, L.L.P. New York,
Margaret Polson Polson Intellectual Property Law, PC US Design Patents Overview.
© 2008 International Intellectual Property June 16, 2009 Class 2 Introduction to Patents.
Prosecution Group Luncheon Patent October PTO News Backlog of applications continues to decrease –623,000 now, decreasing about 5,000/ month –Expected.
Double Patenting Deborah Reynolds SPE Art Unit 1632 Detailee, TC1600 Practice Specialist
European Patent Attorneys Chartered Patent Attorneys Trade Mark Attorneys Practical approaches to appeals before the European Patent Office Paul Chapman.
The Impact of Patent Reform on Independent Inventors and Start-up Companies Mark Nowotarski (Patent Agent)
1 TOPIC III - PATENT INVALIDATION PROCEDURES EU-CHINA WORKSHOP ON THE CHINESE PATENT LAW HARBIN, SEPTEMBER 2008 Dr. Gillian Davies.
© 2011 Barnes & Thornburg LLP. All Rights Reserved. This page, and all information on it, is the property of Barnes & Thornburg LLP which may not be reproduced,
Patents 101 March 28, 2006 And now, for something new, useful and not obvious.
PCT-FILING SYSTEM.
Patents 101 March 28, 2006 And now, for something new, useful and not obvious.
Tech Mahindra Limited v Commissioner of Taxation
Obviousness-type Double Patenting
AIPLA ID Committee Meeting AIPLA Spring Meeting (Seattle) May 2, 2013
PATENT OFFICE PROSECUTION
Alexandria, Virginia July 21, 2014
Nick Reeve Reddie & Grose LLP
Auditing & Investigations II
PATC Module 2 – Infringement/Validity
Preparing a Patent Application
Processes Which Employ Non-Obvious Products
Loss of Right Provisions
Options to Protect an Invention: the Patent Cooperation Treaty (PCT) and Trade Secrets Hanoi October 24, 2017 Peter Willimott Senior Program Officer WIPO.
Patentability of AI related inventions
The Spanish doctrine of equivalents after alimta®
Wisdom of the Board Ex parte PTAB Decisions Show Effective Arguments to Overcome an Obviousness Rejection Trent Ostler The content is exclusively the.
Recognizing an AIA Patent
PATC Module 2 – Infringement/Validity
Preparing a Patent Application
PTAB Bar Association Conference—March 2, 2017
Upcoming changes in the European Patent Office practice on allowing claim amendments in pending patent applications (Article 123(2) EPC) Christof Keussen.
UNION-IP UNION of European Practitioners in Intellectual Property
Position of the Board of Appeal in the legal protection system for Community plant variety rights Gert Würtenberger.
Jonathan D’Silva MMI Intellectual Property 900 State Street, Suite 301
Presentation transcript:

George Kapsalas Patentbüro Paul Rosenich AG AN INTRODUCTION TO THE EUROPEAN PATENTING PROBLEM OF TOXIC PRIORITIES, POISONOUS DIVISIONALS DISCUSSION THEME 2 AIPLA Patent Law Committee January 13, 2016 George Kapsalas Patentbüro Paul Rosenich AG

To stay oriented, start from home: Santarus, Inc. v. Par Pharmaceutical, Inc., 694 F.3d 1344 (Fed. Cir. 2012) In re Chu, 66 F.3d 292, 296–97 (Fed. Cir. 1995) and do revisit: In re Van Langenhoven, 458 F.2d 132, 136–37 (C.C.P.A. 1972)

Keep a “gem” with you: “As to given claimed subject matter, only one effective date is applicable. Whether or not the requirements of section 120 are satisfied is determinative of that date, and in the case of the [B] claims, those requirements have not been met. Accordingly, the [foreign, priority-based] patent may properly be relied upon for all it fairly teaches to establish obviousness, under 35 U.S.C. § 103, of the subject matter defined in the [B] claims.” In re Van Langenhoven

The Santarus minority opinion, also useful: “The panel majority forgets that ‘matter disclosed in the parent application is entitled to the benefit of the filing date of the parent application.’ Waldemar Link, GmbH & Co. v. Osteonics Corp., 32 F.3d 556, 558 (Fed. Cir. 1994);....Instead, the panel majority relies upon the common subject matter from the ’737[parent] patent disclosure to invalidate the ’885[CIP] claims supported by that subject matter. This is incorrect, for the common subject matter in the ’885 patent is entitled to the ’737 filing date. That entitlement is not lost by issuance of the ’737 patent. The common subject matter, properly carried forward in copending continuing patents, cannot be prior art against itself, as the majority holds.”

The Santarus minority opinion, conceptually: A claim for priority to any parent, removes the content of the parent from the prior art ?

And so, on this visit to EPO practice, the amount of travel required on your part is perhaps less than you might have originally thought.

EPO Primary Statutes on Priority European Patent Convention (EPC) Articles 87, 88 88(2) Multiple priorities may be claimed in respect of a European patent application, notwithstanding the fact that they originated in different countries. Where appropriate, multiple priorities may be claimed for any one claim. Where multiple priorities are claimed, time limits which run from the date of priority shall run from the earliest date of priority. 88(3) If one or more priorities are claimed in respect of a European patent application, the right of priority shall cover only those elements of the European patent application which are included in the application or applications whose priority is claimed. 87(1) “…in respect of the same invention, a right of priority during a period of twelve months from the date of filing…”

Thus, it seems mandated by statute (EPC Art Thus, it seems mandated by statute (EPC Art. 88(2)) that independent CLAIM 1 (an “OR” claim) may look like this, with different priority dates 1,2,3,4,5,6,7

Is there an EPO “CIP”? Hint: bends minds A + B EP1 EP2

The EPO divisional copendency A A

The EPO divisional EPC Article 76 “Divisional Applications” 76(1): ... It may be filed only in respect of subject-matter which does not extend beyond the content of the earlier application as filed… A A

EPO Primary Statute on Novelty European Patent Convention (EPC) Article 54 54(3) ……. the content of [other] European patent applications as filed, the dates of filing of which are prior to the date referred to in paragraph 2 [Comment: the subject appln. date of filing] and which were published on or after that date, shall be considered as comprised in the state of the art. Note also: 54(1) An invention shall be considered to be new if it does not form part of the state of the art.

EPO Statute on Amendments European Patent Convention (EPC) Article 123 123(2) ……. The European patent application or European patent may not be amended in such a way that it contains subject-matter which extends beyond the content of the application as filed….

Arriving to the “Gold Standard” Recently stated by Hon. Klaus Bacher, German Federal Court of Justice: “That an invention must be disclosed directly and unambiguously is required not only under Article 123(2) EPC, but also …. under Article 54(1) EPC….The Federal Court of Justice has observed in almost all the decisions presented to you today that…. the same standards have to be applied as under Article 123(2) EPC. It also applies these standards in the context of Article 87(1) EPC, namely when deciding whether an earlier application from which priority is claimed relates to the same invention.” [But] “for the purposes of Article 54(1) EPC, all that matters is whether the technical teaching claimed by the patent is disclosed in the prior document. The additional requirement that the teaching must be disclosed in the prior document as forming part of the invention applies solely for the purposes of Articles 123(2) and 87(1) EPC.”

Arriving to the “Gold Standard” directly and unambiguously is required not only under Article 123(2) (AMENDMENTS) also …. under Article 54(1) EPC….(NOVELTY) in the context of Article 87(1) EPC…..(PRIORITY) and thus surely as to Article 76(1) EPC…..(DIVISIONALS)

Arriving to the “Gold Standard” directly and unambiguously This is very likely to be strongly supported/defended/preserved in the forthcoming resolution of the pending Referral to the Enlarged Board of Appeals G 1/15 (identifier: “Partial Priority”), whatever the decision be.

A quick comparative view of the “Gold Standard” directly and unambiguously *This slide with thanks-to/courtesy-of : Professor Dr. Cees Mulder, University of Maastricht

But a look back to Santarus A claim for priority to any parent, removes the content of the parent from the prior art ?

Fundamental contributors to current problem Art. 88(2) – multiple priorities in one claim Art. 54(3) – no distinction, as pre-AIA 35 U.S.C. 102(e) “by another” Art. 89 – priority date = EPO filing date Prior Enlarged Board of Appeals decision G 2/98 interpreting Art.88(2) gave some guidance as to 88(2)

G 2/98 where a first priority document discloses a feature A, and a second priority document discloses a feature B for use as an alternative to feature A, then a claim directed to A or B can enjoy the first priority for part A of the claim and the second priority for part B of the claim. It is further suggested that these two priorities may also be claimed for a claim directed to C, if the feature C, either in the form of a generic term or formula, or otherwise, encompasses feature A as well as feature B. The use of a generic term or formula in a claim for which multiple priorities are claimed ….is perfectly acceptable under Articles 87(1) and 88(3) EPC, provided that it gives rise to the claiming of a limited number of clearly defined alternative subject-matters.

“a limited number of clearly defined alternative subject-matters”

Generic “C” unprotected, anticipated? Generic C(alone loses priority?) C A (priority) “A or C” ? claimed?

G 1/15 (identifier: “Partial Priority/Infineum”) http://www.epo.org/law-practice/case-law-appeals/recent/t130557ex1.html https://register.epo.org/application?number=EP98203458&tab=doclist

GB priority EP1 (as PCT) EP2 DIVISIONAL

any priority EP1/PCT EP2 DIVISIONAL

any priority EP1 /PCT EP2 DIVISIONAL

And direct EP priority A diclosed, no C C generic claimed EP1/PCT, 12 month Paris Convention Priority EP1/PCT, published EP2/PCT

Harmony? Patentbüro Paul Rosenich AG BGZ 12 Rotenbodenstrasse DISCLAIMER: This presentation is intended solely for educational and informative purposes. It is not, and is not intended to be , nor intended to replace, specific or general legal advice renderable only by duly qualified legal practitioner(s). This presentation represents the views of the identified author only. George Kapsalas Patentbüro Paul Rosenich AG BGZ 12 Rotenbodenstrasse Triesenberg, LI LI-9497 kapsalas(at)rosenich.com